Are Amyloid Peptides Potential Therapeutics for Sepsis?
Original Article Reference
This SciPod is a summary of the paper ‘An amyloidogenic hexapeptide derived from amylin attenuates inflammation and acute lung injury in murine sepsis’ published in the open access journal PLOS ONE:
About this episode
Amyloids are aggregates of polymerised proteins. The polymerised proteins do not fold as they should and adopt shapes that enable multiple copies to stick together. In humans, these clusters of proteins form fibrils and the presence of these amyloid protein clusters are associated with disease pathologies. In a recent study, Dr Sidharth Mahapatra and colleagues at Stanford University assessed their hypothesis, that, contrary to much of the work in this area, in some cases, amyloids may be beneficial in treating inflammation caused by serious, life-threatening conditions, such as sepsis.
This work is licensed under a Creative Commons Attribution 4.0 International License.
What does this mean?
Share: You can copy and redistribute the material in any medium
Adapt: You can change, and build upon the material for any
purpose, even commercially.
Credit: You must give appropriate credit, provide a link to the
license, and indicate if changes were made.
Increase the impact of your research
• Good science communication encourages everyday people to be scientifically literate so that they can analyse the integrity and legitimacy of information.
• Good science communication encourages people into STEM-related fields of study and employment.
• Good public science communication fosters a community around research that includes both members of the public, policymakers and scientists.
• In a recent survey, 75% of people suggested they would prefer to listen to an interesting story than read it.
Upload your science paper
SciPod script written
Voice audio recorded